MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

MTD · NYSE

Mettler-Toledo International, Inc.

Industrials · Biotechnology: Laboratory Analytical Instruments

Reference price$1,388.38As of Jul 28, 2026
Market capitalization$28.06B
52-week range$1,023.05–$1,525.17
S&P 500 portfolio weight0.04%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$1,180.00-15.0% vs. reference
Average$1,338.78-3.6% vs. reference
High$1,550.00+11.6% vs. reference
5 Buy5 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportJul 30, 2026Jun 2026
Consensus EPS$10.784 estimates
Expected range$10.72–$10.84Low to high EPS
Dec 2026$46.63Street EPS consensus
Dec 2027$51.63Street EPS consensus
Dec 2028$57.76Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+4.0% YoY$4.03B$3.87B
Operating income$1.1B$1.11B
Net income$0.87B$0.86B
Operating cash flow$0.96B$0.97B
Capital expenditures($0.11B)($0.1B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Zacks

Mettler-Toledo (MTD) Earnings Expected to Grow: Should You Buy?

Zacks

Mettler-Toledo (MTD) Upgraded to Buy: Here's What You Should Know

Zacks

Are Options Traders Betting on a Big Move in Mettler-Toledo Stock?

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.